Charmacy Pharmaceutical Co., Ltd. (HKG:2289)

Hong Kong · Delayed Price · Currency is HKD

6.80

-0.50 (-6.85%)

Jul 21, 2026, 6:09 PM HKT

Charmacy Pharmaceutical Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4,385	4,385	4,435	4,404	4,175	3,794
Revenue Growth	3.33%	-1.15%	0.72%	5.47%	10.06%	-4.96%
Gross Profit	336.01	336.01	320.88	288.38	268.61	234.12
Operating Income	131.54	131.54	135.31	108.28	93.49	74.42
Net Income	46.27	46.27	53.28	51.34	90.47	23.15
Earnings Per Share	0.43	0.43	0.49	0.48	0.84	0.21
EPS Growth	-4.14%	-13.15%	3.79%	-43.25%	290.72%	-42.90%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	764.65	764.65	573.86	644.76	503.81	641.76
Total Debt	1,837	1,837	1,409	1,375	1,186	1,327
Net Cash (Debt)	-1,073	-1,073	-835.6	-729.76	-681.72	-685.4
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-9.93	-9.93	-7.74	-6.76	-6.31	-6.35

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	270.89	270.89	106.04	-96.54	44.05	-19.54
Capital Expenditures	-7.47	-7.47	-15.73	-40.85	-8.59	-25.04
Free Cash Flow	263.42	263.42	90.31	-137.39	35.46	-44.58
Free Cash Flow Growth	6.74%	191.69%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	7.66%	7.66%	7.23%	6.55%	6.43%	6.17%
Operating Margin	3.00%	3.00%	3.05%	2.46%	2.24%	1.96%
Pretax Margin	1.47%	1.47%	1.61%	1.53%	2.92%	0.87%
Profit Margin	1.05%	1.05%	1.20%	1.17%	2.17%	0.61%
FCF Margin	6.01%	6.01%	2.04%	-3.12%	0.85%	-1.18%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.348	0.300	0.450	0.300	0.450
Dividend Per Share Growth	-29.74%	-33.33%	50.00%	-33.33%	-
Dividend Yield	5.36%	4.87%	5.54%	2.96%	9.14%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	13.63	15.29	18.67	24.75	7.28	21.21
Forward PE	-	13.45	13.45	13.45	13.45	13.45
P/FCF Ratio	2.39	2.69	11.01	-	18.56	-
PS Ratio	0.14	0.16	0.22	0.29	0.16	0.13